$178B
$592 Million
0.08% of portfolio
5,133
Q2 2025
Added 0.23%
$5.34B
$640 Million
0.08% of portfolio
8,600
Q1 2025
Reduced 4.44%
$70.6B
$615 Million
0.08% of portfolio
5,842
Q2 2025
Reduced 41.49%
-
$643 Million
0.08% of portfolio
-
Q2 2025
Reduced 15.78%
-
$630 Million
0.08% of portfolio
-
Q2 2025
Reduced 10.95%
$57.3B
$625 Million
0.08% of portfolio
3,192
Q2 2025
Reduced 20.85%
$120B
$647 Million
0.08% of portfolio
7,215
Q2 2025
Added 4.52%
$4.12B
$562 Million
0.07% of portfolio
7,079
Q2 2024
Reduced 3.71%
$9.81B
$573 Million
0.07% of portfolio
6,633
Q2 2025
Reduced 25.21%
$2.68B
$569 Million
0.07% of portfolio
7,623
Q2 2025
Added 64.47%
$15.6B
$582 Million
0.07% of portfolio
4,600
Q2 2025
Added 9.52%
$54.7B
$520 Million
0.07% of portfolio
8,923
Q2 2025
Added 17.83%
$0
$513 Million
0.07% of portfolio
2,642
Q2 2025
Reduced 40.27%
$22.8B
$573 Million
0.07% of portfolio
9,000
Q2 2024
Reduced 19.64%
$15.5B
$564 Million
0.07% of portfolio
3,338
Q2 2025
Reduced 8.82%
$27.5B
$561 Million
0.07% of portfolio
22,942
Q2 2025
Added 14.33%
$2.38B
$513 Million
0.07% of portfolio
12,644
Q2 2025
Reduced 3.43%
$44.5B
$513 Million
0.07% of portfolio
49,440
Q2 2025
Reduced 7.14%
Ge Healthcare Technologies I
-
$535 Million
0.07% of portfolio
-
Q2 2025
Added 48.98%
$203B
$542 Million
0.07% of portfolio
18,741
Q2 2025
Added 217.05%
$138B
$576 Million
0.07% of portfolio
23,773
Q2 2025
Added 9.89%
-
$514 Million
0.07% of portfolio
-
Q2 2025
New
$23.5B
$566 Million
0.07% of portfolio
2,411
Q2 2025
Added 7.16%
$3.62B
$524 Million
0.07% of portfolio
13,164
Q2 2025
Added 1.46%
$4.04B
$521 Million
0.07% of portfolio
12,221
Q2 2025
New
Ares Management Corporation
-
$581 Million
0.07% of portfolio
-
Q2 2025
Added 24.07%
-
$466 Million
0.06% of portfolio
-
Q2 2025
Added 310.74%
$0
$483 Million
0.06% of portfolio
5,923
Q4 2024
Added 83.2%
$12.1B
$454 Million
0.06% of portfolio
15,000
Q2 2025
Added 2.04%
$250B
$451 Million
0.06% of portfolio
3,202
Q2 2025
Reduced 2.2%
$7.06B
$461 Million
0.06% of portfolio
8,079
Q2 2025
Added 2.67%
$1.95B
$499 Million
0.06% of portfolio
8,466
Q2 2025
Added 9.2%
-
$484 Million
0.06% of portfolio
-
Q2 2025
Reduced 10.88%
-
$461 Million
0.06% of portfolio
-
Q1 2025
Reduced 45.73%
$229B
$472 Million
0.06% of portfolio
3,471
Q2 2025
Added 0.99%
-
$451 Million
0.06% of portfolio
-
Q2 2025
Reduced 14.61%
$5.94B
$506 Million
0.06% of portfolio
4,465
Q2 2025
Reduced 3.79%
Alnylam Pharmaceuticals Inc
-
$478 Million
0.06% of portfolio
-
Q2 2025
Reduced 7.54%
$2.05B
$445 Million
0.06% of portfolio
10,399
Q2 2024
Reduced 16.72%
$11.9B
$444 Million
0.06% of portfolio
8,600
Q1 2025
Added 2.38%
$257B
$436 Million
0.06% of portfolio
3,600
Q2 2025
Reduced 5.26%
$26.5B
$456 Million
0.06% of portfolio
3,600
Q4 2024
Reduced 21.74%
-
$488 Million
0.06% of portfolio
-
Q2 2024
New
$16.9B
$503 Million
0.06% of portfolio
9,645
Q2 2025
Added 56.96%
-
$504 Million
0.06% of portfolio
-
Q2 2025
New
$1.19B
$471 Million
0.06% of portfolio
5,900
Q2 2025
Added 9.91%
$1.17B
$446 Million
0.06% of portfolio
19,050
Q2 2025
Added 9.17%
-
$501 Million
0.06% of portfolio
-
Q2 2025
Reduced 25.78%
$86.2B
$449 Million
0.06% of portfolio
1,540
Q2 2025
Reduced 8.93%
$2.43B
$482 Million
0.06% of portfolio
9,104
Q2 2025
Added 65.98%